Blocking the EGFR signaling pathway by inhibiting tyrosine kinase can result in the death of cancer cells.558 Hence, identifying effective drug delivery systems for EGFR signaling inhibitors is a crucial objective in the treatment of lung cancer. This evidence concerns the gene EGFR and cancer.